JA. DHEA replacement for postmenopausal women: placebo or panacea? Climacteric. 2015;18(4):439–40. https://pubmed.ncbi.nlm.nih.gov/25731680/

5966

Elraiyah T, Sonbol MB, Wang Z, et al. Clinical review: the benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(10):3536–42. https://pubmed.ncbi.nlm.nih.gov/25279571/

5967

U.S. Food and Drug Administration. FDA approves Intrarosa for postmenopausal women experiencing pain during sex. FDA.gov. https://www.fda.gov/news-events/press-announcements/fda-approves-intrarosa-postmenopausal-women-experiencing-pain-during-sex. Published November 17, 2016. Accessed Sept 26, 2022.; https://www.fda.gov/news-events/press-announcements/fda-approves-intrarosa-postmenopausal-women-experiencing-pain-during-sex

5968

Labrie F, Martel C, Bérubé R, et al. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens. J Steroid Biochem Mol Biol. 2013;138:359–67. https://pubmed.ncbi.nlm.nih.gov/23954500/

5969

Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92(12):1842–9. https://pubmed.ncbi.nlm.nih.gov/29202940/

5970

Di Donato V, Schiavi MC, Iacobelli V, et al. Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part II: evaluation of tolerability and safety. Maturitas. 2019;121:93–100. https://pubmed.ncbi.nlm.nih.gov/30509754/

5971

Gold EB. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am Journal Epidemiol. 2000;152(5):463–73. https://pubmed.ncbi.nlm.nih.gov/10981461/

5972

Ghazanfarpour M, Roudsari RL, Treglia G, Sadeghi R. Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women: a systematic review of randomised controlled trials. J Obstet Gynaecol. 2015;35(8):783–7. https://pubmed.ncbi.nlm.nih.gov/25710207/

5973

Lima SMRR, Bernardo BFA, Yamada SS, Reis BF, da Silva GMD, Galvão MAL. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial. Maturitas. 2014;78(3):205–11. https://pubmed.ncbi.nlm.nih.gov/24856055/

5974

Lima SMRR, Yamada SS, Reis BF, Postigo S, Galvão da Silva MAL, Aoki T. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas. 2013;74(3):252–8. https://pubmed.ncbi.nlm.nih.gov/23312487/

5975

Zhang J, Zhu Y, Pan L, Xia H, Ma J, Zhang A. Soy isoflavone improved female sexual dysfunction of mice via endothelial nitric oxide synthase pathway. Sex Med. 2019;7(3):345–51. https://pubmed.ncbi.nlm.nih.gov/31303464/

5976

Nikander E, Rutanen EM, Nieminen P, Wahlström T, Ylikorkala O, Tiitinen A. Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertil Steril. 2005;83(1):137–42. https://pubmed.ncbi.nlm.nih.gov/15652899/

5977

Nourozi M, Haghollahi F, Ramezanzadeh F, Hanachi P. Effect of soy milk consumption on quality of life in Iranian postmenopausal women. J Family Reprod Health. 2015;9(2):93–100. https://pubmed.ncbi.nlm.nih.gov/26175764/

5978

Hanachi P, Golkho S. The effect of soymilk on menopausal symptoms and total antioxidant levels in menopausal women. Malaysian J Med Health Sci. 2008;4(1):33–40. https://www.researchgate.net/publication/267037285_The_effect_of_soymilk_on_menopausal_symptoms_and_total_antioxidant_levels_in_menopausal_women

5979

Padmaqriya S, Kumar SS. Quality of life of postmenopausal women receiving plant-based phytoestrogens. Int J Pharm Sci Res. 2020;11(10):4998–5003. https://ijpsr.com/bft-article/quality-of-life-of-postmenopausal-women-receiving-plant-based-phytoestrogens/

5980

Amsterdam A, Abu-Rustum N, Carter J, Krychman M. Persistent sexual arousal syndrome associated with increased soy intake. J Sex Med. 2005;2(3):338–40. https://pubmed.ncbi.nlm.nih.gov/16422864/

5981

Omidvar S, Esmailzadeh S, Baradaran M, Basirat Z. Effect of fennel on pain intensity in dysmenorrhoea: a placebo-controlled trial. Ayu. 2012;33(2):311–3. https://pubmed.ncbi.nlm.nih.gov/23559811/

5982

Modaress Nejad V, Asadipour M. Comparison of the effectiveness of fennel and mefenamic acid on pain intensity in dysmenorrhoea. East Mediterr Health J. 2006;12(3–4):423–7. https://pubmed.ncbi.nlm.nih.gov/17037712/

5983

Ghazanfarpour M, Shokrollahi P, Khadivzadeh T, et al. Effect of Foeniculum vulgare (fennel) on vaginal atrophy in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Post Reprod Health. 2017;23(4):171–6. https://pubmed.ncbi.nlm.nih.gov/28990439/

5984

Ghaffari P, Hosseininik M, Afrasiabifar A, et al. The effect of Fennel seed powder on estradiol levels, menopausal symptoms, and sexual desire in postmenopausal women. Menopause. 2020;27(11):1281–6. https://pubmed.ncbi.nlm.nih.gov/33110044/

5985

Yaralizadeh M, Abedi P, Najar S, Namjoyan F, Saki A. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: a double-blind randomized placebo-controlled trial. Maturitas. 2016;84:75–80. https://pubmed.ncbi.nlm.nih.gov/26617271/

5986

Mazalzadeh F, Hekmat K, Namjouyan F, Saki A. Effect of Trigonella foenum (fenugreek) vaginal cream on vaginal atrophy in postmenopausal women. J Family Med Prim Care. 2020;9(6):2714–9. https://pubmed.ncbi.nlm.nih.gov/32984113/

5987

Abedi P, Najafian M, Yaralizadeh M, Namjoyan F. Effect of fennel vaginal cream on sexual function in postmenopausal women: a double blind randomized controlled trial. J Med Life. 2018;11(1):24–8. https://pubmed.ncbi.nlm.nih.gov/29696061/

5988

Poole C, Bushey B, Foster C, et al. The effects of a commercially available botanical supplement on strength, body composition, power output, and hormonal profiles in resistance-trained males. J Int Soc Sports Nutr. 2010;7:34. https://pubmed.ncbi.nlm.nih.gov/20979623/

5989

Mansoori A, Hosseini S, Zilaee M, Hormoznejad R, Fathi M. Effect of fenugreek extract supplement on testosterone levels in male: a meta-analysis of clinical trials. Phytother Res. 2020;34(7):1550–5. https://pubmed.ncbi.nlm.nih.gov/32048383/

5990

Rao A, Steels E, Inder WJ, Abraham S, Vitetta L. Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. Aging Male. 2016;19(2):134–42. https://pubmed.ncbi.nlm.nih.gov/26791805/

5991

Bahmani M, Shirzad H, Mirhosseini M, Mesripour A, Rafieian-Kopaei M. A review on ethnobotanical and therapeutic uses of fenugreek (Trigonella foenum-graceum L). J Evid Based Complementary Altern Med. 2016;21(1):53–62. https://pubmed.ncbi.nlm.nih.gov/25922446/

5992

Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L. Influence of a specialized Trigonella foenum-graecum seed extract (libifem), on testosterone, estradiol and sexual function in healthy menstruating women, a randomised placebo controlled study. Phytother Res. 2015;29(8):1123–30. https://pubmed.ncbi.nlm.nih.gov/25914334/

5993

Steels E, Steele ML, Harold M, Coulson